ADVAIR Safety Questions, ADVAIR Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about ADVAIR. Our extensive database of ADVAIR adverse events and ADVAIR warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about ADVAIR

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




ADVAIR Safety Reports

Total ADVAIR reports: 1705.
ADVAIR FDA safety alerts: 2003 2005 .
Reported deaths: 72    Reported hospitalizations: 210.
Take ADVAIR Side Effects Survey or Share Your ADVAIR Story. Read More Here.

Showing 1-75 of 1705 Next >

Consumer or non-health professional from BRAZIL reported ADVAIR problem on Feb 23, 2007. Female patient, 16 years of age, was diagnosed with bronchiectasis, hiv infection and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: acne, amenorrhoea, cushing's syndrome, hypercholesterolaemia, hypertriglyceridaemia. ADVAIR dosage: unknown. During the same period patient was treated with STAVUDINE, LAMIVUDINE. Patient recovered.

ADVAIR problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 12, 2007. Male patient, 74 years of age, weighting 223.5 lb, was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: adrenal insufficiency, blood cortisol decreased. ADVAIR dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ADVAIR problem on Mar 12, 2007. Male patient, 61 years of age, was diagnosed with asthma and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, diplopia, dizziness. ADVAIR dosage: unknown. During the same period patient was treated with ZOCOR, VITAMINS. Patient recovered.

ADVAIR problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2007. Female patient, 52 years of age, was diagnosed with asthma and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: detachment of retinal pigment epithelium, eye disorder, metamorphopsia, retinal haemorrhage, vision blurred. ADVAIR dosage: unknown. During the same period patient was treated with NASONEX. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ADVAIR problem on Mar 13, 2007. Male patient, 81 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: exostosis, fall, infection, myocardial ischaemia, neck injury, syncope. ADVAIR dosage: unknown. During the same period patient was treated with SPIRIVA, ACTOS, FLOMAX, ZANTAC, PLETAL, LIPITOR, GLIPIZIDE, AMIODARONE. Patient was hospitalized. Patient died on 12/12/2006.

ADVAIR problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 13, 2007. Female patient, 53 years of age, was diagnosed with asthma and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: eye disorder, resorption bone increased, retinal detachment, vision blurred, vitreous floaters. ADVAIR dosage: unknown. During the same period patient was treated with ACCOLATE, NASONEX, ASTELIN, KADIAN, XOLAIR. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ADVAIR problem on Dec 15, 2006. Female patient, 66 years of age, was diagnosed with asthma and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: dyspnoea, headache, neck pain. ADVAIR dosage: unknown. During the same period patient was treated with PROTONIX, MEGESTROL ACETATE, TOPROL, CLARITIN, RESTORIL. Patient recovered.

ADVAIR problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 06, 2007. Female patient, 78 years of age, weighting 148.4 lb, was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: night sweats. ADVAIR dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ADVAIR problem on Jan 10, 2007. Female patient was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: urticaria. ADVAIR dosage: unknown. Patient recovered.

ADVAIR problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 18, 2007. Female patient, 75 years of age, was diagnosed with asthma and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: cough, dysphonia. ADVAIR dosage: unknown. During the same period patient was treated with ALBUTEROL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ADVAIR problem on Feb 01, 2007. Female patient, 60 years of age, weighting 133.4 lb, was diagnosed with bronchitis and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: cough. ADVAIR dosage: unknown. During the same period patient was treated with MONISTAT, MYCOLOG. Patient recovered.

ADVAIR problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 31, 2007. Female patient, 52 years of age, was diagnosed with asthma and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: lip disorder. ADVAIR dosage: unknown. During the same period patient was treated with LEXAPRO, CELEBREX. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ADVAIR problem on Feb 20, 2007. Female patient, 83 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: cough. ADVAIR dosage: unknown. During the same period patient was treated with SPIRIVA, PREDNISOLONE EYE DROPS, ALBUTEROL. Patient recovered.

ADVAIR problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 22, 2007. Male patient, child 5 years of age, was diagnosed with asthma and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: asthma. ADVAIR dosage: unknown. During the same period patient was treated with PULMICORT NEBULISED, FLORATIL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ADVAIR problem on Feb 23, 2007. Female patient, 48 years of age, was diagnosed with asthma and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: chest discomfort, dyspnoea. ADVAIR dosage: unknown. During the same period patient was treated with ZYRTEC, SINGULAIR, NASACORT, ASTELIN, LIPITOR, ALBUTEROL. Patient recovered.

ADVAIR problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2007. Male patient was diagnosed with asthma and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: dysphonia. ADVAIR dosage: unknown. During the same period patient was treated with ADVAIR DISKUS. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ADVAIR problem on Mar 13, 2007. Female patient, 68 years of age, weighting 162.3 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: chest pain, hypoaesthesia. ADVAIR dosage: unknown. During the same period patient was treated with ALBUTEROL, IPRATROPIUM BROMIDE, DIOVAN, CLONIDINE. Patient was hospitalized. Patient recovered.

ADVAIR problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2007. Female patient, 49 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: asthma. ADVAIR dosage: unknown. During the same period patient was treated with COREG, DUONEB, ALBUTEROL, FUROSEMIDE, CLONAZEPAM, FLUOXETINE, METFORMIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ADVAIR problem on Mar 13, 2007. Female patient, 62 years of age, was diagnosed with asthma and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: arthralgia, chest pain, muscle spasms, nervousness, pneumonia, urticaria, visual acuity reduced, wheezing. ADVAIR dosage: unknown. During the same period patient was treated with NASONEX, HYDROCHLOROTHIAZIDE, TRIAMTEREN, CALTRATE, NEXIUM, ALBUTEROL. Patient was hospitalized. Patient recovered.

ADVAIR problem was reported by a Health Professional from UNITED STATES on Mar 13, 2007. Female patient, weighting 109.1 lb, was diagnosed with asthma, gastrooesophageal reflux disease, skin wrinkling and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: asthma, dehydration, depression, facial paresis, fatigue, gastrooesophageal reflux disease, headache, heart rate increased, hypersensitivity. ADVAIR dosage: unknown. During the same period patient was treated with ZANTAC, BOTOX COSMETIC. Patient was hospitalized and became disabled. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ADVAIR problem on Mar 15, 2007. Male patient, 52 years of age, was diagnosed with asthma and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: blood amylase increased, lipase increased. ADVAIR dosage: unknown. During the same period patient was treated with SINGULAIR, PREVACID. Patient recovered.

ADVAIR problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 15, 2007. Female patient, 64 years of age, weighting 150.4 lb, was diagnosed with asthma and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: disorientation, faecal incontinence, grand mal convulsion, loss of consciousness, postictal state, urinary incontinence. ADVAIR dosage: unknown. During the same period patient was treated with SINGULAIR, FLOMAX, THYROID. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ADVAIR problem on Mar 14, 2007. Male patient, child 11 years of age, was diagnosed with asthma and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: adverse event. ADVAIR dosage: unknown. During the same period patient was treated with SINGULAIR. Patient was hospitalized. Patient recovered.

ADVAIR problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 15, 2007. Female patient, 70 years of age, weighting 194.4 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: confusional state, dysphagia, dysphonia, memory impairment, middle insomnia, nausea, palpitations, urinary incontinence, weight increased. ADVAIR dosage: unknown. During the same period patient was treated with IPRATROPIUM BROMIDE, XOPENEX, XANAX. Patient recovered.

Health Professional from UNITED STATES reported ADVAIR problem on Mar 20, 2007. Male patient, 50 years of age, weighting 200.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: chest discomfort, productive cough. ADVAIR dosage: unknown. Patient recovered.

ADVAIR problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 19, 2007. Female patient, 91 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: eye disorder, glaucoma. ADVAIR dosage: unknown. During the same period patient was treated with SPIRIVA, TOPRAL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ADVAIR problem on Mar 19, 2007. Male patient, 71 years of age, was diagnosed with asthma and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, kidney infection, nephrolithiasis, productive cough. ADVAIR dosage: unknown. During the same period patient was treated with SINGULAIR, CENTRUM SILVER, ATACAND HCT, FINASTERIDE, UROXATRAL. Patient recovered.

ADVAIR problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 19, 2007. Male patient, 30 years of age, was diagnosed with asthma and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: decreased immune responsiveness, respiratory tract infection. ADVAIR dosage: unknown. During the same period patient was treated with ANTIBIOTIC, ALBUTEROL, ALLEGRA D. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ADVAIR problem on Mar 19, 2007. Male patient was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: adverse event, overdose. ADVAIR dosage: unknown. Patient was hospitalized. Patient recovered.

ADVAIR problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 19, 2007. Male patient, 65 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: arrhythmia, oral mucosal disorder. ADVAIR dosage: unknown. During the same period patient was treated with LOTREL, LOPRESSOR, PERPHENAZINE, KLONOPIN, OMEPRAZOLE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ADVAIR problem on Mar 20, 2007. Female patient, 52 years of age, was diagnosed with asthma and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: eye disorder, maculopathy. ADVAIR dosage: unknown. During the same period patient was treated with LOTENSIN, ALBUTEROL, PREMARIN. Patient was hospitalized. Patient recovered.

ADVAIR problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 20, 2007. Male patient, 50 years of age, was diagnosed with asthma, eye disorder and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: eye disorder, eye haemorrhage, eye irritation, visual acuity reduced, visual field defect. ADVAIR dosage: unknown. During the same period patient was treated with PREDNISOLONE ACETATE, LOPID, NAPROSYN, CLARINEX, CARDURA, SINGULAIR, ATACAND, LIPITOR. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ADVAIR problem on Mar 21, 2007. Female patient, 13 years of age, was diagnosed with hypersensitivity and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: anorexia, dialysis, ear infection, immunosuppression, lethargy, renal failure. ADVAIR dosage: unknown. Patient was hospitalized. Patient recovered.

ADVAIR problem was reported by a Physician from CANADA on Mar 19, 2007. Male patient, 25 years of age, weighting 165.3 lb, was diagnosed with asthma and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: asthma, cardio-respiratory arrest, depressed level of consciousness, foreign body aspiration, hyporeflexia. ADVAIR dosage: unknown. During the same period patient was treated with SEREVENT, FLOVENT, VENTOLIN HFA, PREDNISONE, PERCOCET, NEURONTIN, OXYCONTIN. Patient died on 10/03/2003.

Consumer or non-health professional from UNITED STATES reported ADVAIR problem on Mar 19, 2007. Male patient, 73 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: bronchitis, fungal infection, pneumonia, productive cough. ADVAIR dosage: unknown. During the same period patient was treated with COUMADIN, LIPITOR, ATENOLOL, WELLBUTRIN. Patient recovered.

ADVAIR problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 19, 2007. Female patient, 56 years of age, was treated with ADVAIR. ADVAIR dosage: unknown. Patient died on 12/19/2005.

Consumer or non-health professional from UNITED STATES reported ADVAIR problem on Mar 19, 2007. Female patient, 80 years of age, was diagnosed with asthma and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: eye haemorrhage, maculopathy, visual acuity reduced. ADVAIR dosage: unknown. Patient recovered.

ADVAIR problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 21, 2007. Female patient, 50 years of age, was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: dyspnoea, eye pain, headache, heart rate increased, throat tightness, tremor. ADVAIR dosage: unknown. During the same period patient was treated with LOTENSIN, PREDNISONE, ANTIBIOTIC. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ADVAIR problem on Mar 26, 2007. Female patient, 62 years of age, was diagnosed with asthma and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: asthma, cataract nuclear, dyspnoea, osteoporosis, visual disturbance. ADVAIR dosage: unknown. During the same period patient was treated with HYOSCYAMINE, NORVASC, EFFEXOR. Patient recovered.

ADVAIR problem was reported by a Physician from CANADA on Mar 27, 2007. Female patient, 75 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: cellulitis, dysphonia. ADVAIR dosage: unknown. During the same period patient was treated with METHOTREXATE. Patient recovered.

Physician from CANADA reported ADVAIR problem on Mar 23, 2007. Male patient, 25 years of age, weighting 165.3 lb, was diagnosed with asthma and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: asthma, bronchitis, cardio-respiratory arrest, depressed level of consciousness, dyspnoea, foreign body aspiration, hyporeflexia, pneumonia, productive cough. ADVAIR dosage: unknown. During the same period patient was treated with SEREVENT, FLOVENT, VENTOLIN HFA, TYLENOL W, PREDNISONE, PERCOCET, NEURONTIN, OXYCONTIN. Patient was hospitalized. Patient died on 10/03/2003.

ADVAIR problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 23, 2007. Female patient, 74 years of age, was diagnosed with asthma and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: asthenia, cough, nasopharyngitis, pneumonia, wheezing. ADVAIR dosage: unknown. During the same period patient was treated with NEBULIZER, INDERAL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ADVAIR problem on Mar 23, 2007. Male patient, 68 years of age, was diagnosed with emphysema and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: pneumonia, prescribed overdose. ADVAIR dosage: unknown. During the same period patient was treated with COMBIVENT, NEBULIZER. Patient recovered.

ADVAIR problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 26, 2007. Female patient, 62 years of age, was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: circulatory collapse, dizziness, fatigue, muscular weakness, orthostatic hypotension. ADVAIR dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ADVAIR problem on Mar 26, 2007. Female patient, 67 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: adverse event. ADVAIR dosage: unknown. Patient was hospitalized. Patient recovered.

ADVAIR problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 27, 2007. Male patient, 83 years of age, was diagnosed with asthma and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: visual acuity reduced. ADVAIR dosage: unknown. During the same period patient was treated with REFRESH, ZAROXOLYN, APRESOLINE, OXAZEPAM. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ADVAIR problem on Mar 27, 2007. Female patient, 67 years of age, was diagnosed with emphysema and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: cataract, intraocular pressure increased, muscular weakness. ADVAIR dosage: unknown. During the same period patient was treated with DIAMOX, DARVOCET, COMBIVENT, ALLOPURINOL, LIPITOR, CYMBALTA. Patient recovered.

ADVAIR problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 27, 2007. Male patient, 45 years of age, was diagnosed with asthma, hypertension and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: dry eye, eye haemorrhage, somnolence, venous valve ruptured, wheezing. ADVAIR dosage: unknown. During the same period patient was treated with COREG, GLUCOPHAGE, NIASPAN, ASPIRIN, MICARDIS. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ADVAIR problem on Mar 27, 2007. Male patient, child 10 years of age, weighting 63.05 lb, was diagnosed with asthma and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: anorexia, contusion, growth retardation, heart rate increased, immune system disorder, meningitis, middle ear effusion, peak expiratory flow rate decreased, prescribed overdose. ADVAIR dosage: unknown. During the same period patient was treated with FLONASE, ZYRTEC. Patient was hospitalized. Patient recovered.

ADVAIR problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 30, 2007. Female patient, 51 years of age, weighting 285.0 lb, was diagnosed with bronchospasm, cough and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: bronchospasm, condition aggravated, cough, dysphonia, increased upper airway secretion, rhinorrhoea. ADVAIR dosage: unknown. During the same period patient was treated with ADVAIR DISKUS. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ADVAIR problem on Mar 30, 2007. Female patient, 43 years of age, weighting 230.0 lb, was diagnosed with asthma and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: total lung capacity decreased. ADVAIR dosage: unknown. During the same period patient was treated with ALBUTEROL. Patient recovered.

ADVAIR problem was reported by a Pharmacist from CANADA on Mar 29, 2007. Female patient, weighting 120.2 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: overdose. ADVAIR dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ADVAIR problem on Mar 28, 2007. Male patient, 81 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: exostosis, fall, infection, myocardial ischaemia, neck injury, syncope. ADVAIR dosage: unknown. During the same period patient was treated with SPIRIVA, ACTOS, FLOMAX, ZANTAC, PLETAL, LIPITOR, GLIPIZIDE, AMIODARONE. Patient was hospitalized. Patient died on 12/12/2006.

ADVAIR problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 28, 2007. Female patient was diagnosed with bronchitis, asthma and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: myalgia, oral pain. ADVAIR dosage: unknown. During the same period patient was treated with SEREVENT, NEBULIZER. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ADVAIR problem on Mar 27, 2007. Male patient, 71 years of age, was diagnosed with chronic obstructive pulmonary disease, benign prostatic hyperplasia and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, arthralgia, breast mass, glaucoma, intraocular pressure increased, musculoskeletal pain. ADVAIR dosage: unknown. During the same period patient was treated with AVODART, FLOMAX. Patient was hospitalized. Patient recovered.

ADVAIR problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 29, 2007. Female patient, 78 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: fall, osteoporosis, spinal compression fracture. ADVAIR dosage: unknown. During the same period patient was treated with FLOVENT, SEREVENT, THEOPHYLLINE, ALBUTEROL, ATROVENT, MIACALCIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ADVAIR problem on Mar 29, 2007. Male patient, child 10 years of age, was diagnosed with asthma and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: nausea, status asthmaticus. ADVAIR dosage: unknown. Patient was hospitalized. Patient recovered.

ADVAIR problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 02, 2007. Female patient was diagnosed with emphysema and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: cataract, iritis. ADVAIR dosage: unknown. During the same period patient was treated with SPIRIVA, LIPITOR, FOSAMAX, ASPIRIN, METOPROLOL SUCCINATE, HYDROCHLOROTHIAZIDE, PREDTE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ADVAIR problem on Apr 02, 2007. Female patient, 57 years of age, was diagnosed with asthma and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: cataract, vascular injury, vision blurred, visual acuity reduced. ADVAIR dosage: unknown. During the same period patient was treated with SINGULAIR, ALLEGRA, SYNTHROID, BENICAR, VYTORIN, ZOCOR, NEXIUM. Patient recovered.

ADVAIR problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 02, 2007. Female patient, weighting 185.0 lb, was diagnosed with asthma and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: gastrooesophageal reflux disease. ADVAIR dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ADVAIR problem on Apr 04, 2007. Female patient, 46 years of age, was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: back pain, feeling jittery, nervousness, pollakiuria, visual acuity reduced. ADVAIR dosage: unknown. During the same period patient was treated with VESICARE, SYNTHROID, CYTOMEL, PROGESTERONE, TESTOSTERONE, ESTRADIOL. Patient recovered.

ADVAIR problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 04, 2007. Female patient, 70 years of age, was diagnosed with asthma and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: asthma. ADVAIR dosage: unknown. During the same period patient was treated with ALBUTEROL, SPIRIVA. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ADVAIR problem on Apr 04, 2007. Female patient, 64 years of age, was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: colitis, hypersensitivity. ADVAIR dosage: unknown. Patient recovered.

ADVAIR problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 10, 2007. Female patient, 74 years of age, was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: dyspnoea, respiratory distress. ADVAIR dosage: unknown. During the same period patient was treated with ALBUTEROL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ADVAIR problem on Apr 06, 2007. Female patient, 64 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: nephrolithiasis, osteoporosis. ADVAIR dosage: unknown. During the same period patient was treated with SPIRIVA, ALBUTEROL, ZYFLO, LEVOXYL, BUSPAR, TOPAMAX, PROVIGIL, LEXAPRO. Patient recovered.

ADVAIR problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 10, 2007. Male patient, 71 years of age, was diagnosed with asthma and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, kidney infection, nephrolithiasis, productive cough. ADVAIR dosage: unknown. During the same period patient was treated with SINGULAIR, CENTRUM SILVER, ATACAND HCT, FINASTERIDE, UROXATRAL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ADVAIR problem on Apr 10, 2007. Male patient, child 6 years of age, was diagnosed with asthma and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: asthma, respiratory tract infection. ADVAIR dosage: unknown. During the same period patient was treated with NASONEX, MAXAIR, SINGULAIR, ALLERGY SHOTS. Patient recovered.

ADVAIR problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 05, 2007. Female patient, 74 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: device failure. ADVAIR dosage: unknown. During the same period patient was treated with COMBIVENT, OXYGEN, NORVASC, CLARINEX, HYDRALAZINE, MOBIC, TOPROL, CALTRATE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ADVAIR problem on Apr 03, 2007. Female patient, 81 years of age, was diagnosed with asthma and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: choking, cough, incorrect dose administered. ADVAIR dosage: unknown. During the same period patient was treated with AMLODIPINE, MONTELUKAST. Patient recovered.

ADVAIR problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 03, 2007. Female patient was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: aggression, anger, ill-defined disorder, psychotic disorder. ADVAIR dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ADVAIR problem on Apr 11, 2007. Female patient, 91 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: eye disorder, glaucoma. ADVAIR dosage: unknown. During the same period patient was treated with SPIRIVA, TOPRAL. Patient recovered.

ADVAIR problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 11, 2007. Female patient, 46 years of age, was diagnosed with asthma and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: asthma, cataract, ill-defined disorder, wheezing. ADVAIR dosage: unknown. During the same period patient was treated with ADVAIR DISKUS, SINGULAIR, ALBUTEROL, NEXIUM, DARVOCET, BENTALIN, CLARITIN, NASONEX. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ADVAIR problem on Apr 11, 2007. Female patient, 70 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: hypoglycaemia, tongue ulceration. ADVAIR dosage: unknown. During the same period patient was treated with AVANDARYL, HYTRIN, TORSEMIDE, GLIMEPIRIDE, TOPAMAX. Patient recovered.

ADVAIR problem was reported by a Pharmacist from CANADA on Apr 16, 2007. Female patient, 49 years of age, was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: dyspnoea. ADVAIR dosage: unknown. During the same period patient was treated with SALBUTAMOL, SYNTHROID, CYKLOKAPRON. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ADVAIR problem on Apr 12, 2007. Male patient, 76 years of age, was diagnosed with pneumonia and was treated with ADVAIR. After drug was administered, patient experienced the following problems/side effects: pneumonia. ADVAIR dosage: unknown. Patient recovered.

Showing 1-75 of 1705 Next >

Ask Our Patient Community about ADVAIR

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)